Australia's most trusted
source of pharma news
Posted 24 January 2022 AM
AbbVie continues to clock up wins with Rinvoq after Health Minister Greg Hunt announced it would be reimbursed for Australians with severe atopic dermatitis from next month.
It was a lightning quick trip to PBS listing with PBAC giving the thumbs up in November, the reimbursement decision revealed in an addendum added to Public Summary Documents.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.